Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Rectal Neoplasms 29Esophageal Neoplasms 18Squamous Cell Carcinoma of Head and Neck 15Carcinoma, Non-Small-Cell Lung 14Nasopharyngeal Carcinoma 12Uterine Cervical Neoplasms 11Head and Neck Neoplasms 11Pancreatic Neoplasms 8Oropharyngeal Neoplasms 8Lung Neoplasms 6Glioblastoma 6Carcinoma, Squamous Cell 5Urinary Bladder Neoplasms 4Stomach Neoplasms 4Mouth Neoplasms 4Hypopharyngeal Neoplasms 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Adenocarcinoma 4Radiation Injuries 3Pathologic Complete Response 3Carcinoma 3Breast Neoplasms 3Thymoma 2Resectable Esophageal Cancer 2Neoplasms 2Nasopharyngeal Neoplasms 2NSCLC 2Lymphoma 2Lymphatic Metastasis 2

Interventions

Radiotherapy, Intensity-Modulated 2Paclitaxel 2Cisplatin 2Carboplatin 2pembrolizumab 1fluoroazomycin arabinoside 1fludarabine phosphate 1fludarabine 1cabozantinib 1aldesleukin 1Panitumumab 1Nivolumab 1Metformin 1Interleukin-2 1Hysterectomy 1Fluorouracil 1Docetaxel 1Cyclophosphamide 1Chemoradiotherapy 1Cetuximab 1Albumin-Bound Paclitaxel 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Adenosquamous × Chemoradiotherapy × Clear all
NCT01365156 2021-02-03

Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix

M.D. Anderson Cancer Center

Phase 3 Completed
28 enrolled 8 charts
Gynecologic

Adenocarcinoma, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡